Skip to content
Search

Latest Stories

Poll finds two-thirds of Britons ready for virus jab

Almost two-thirds of people in Britain say they would get vaccinated for Covid-19 but young people are far more likely to refuse a jab than older people, according to an opinion poll published today (Nov 11).

Under new laws announced by the government recently, a wider range of healthcare workers – including pharmacists – will be allowed to deliver Covid-19 vaccines. GPs are expected to play the lead role in a vaccination drive which health secretary Matt Hancock has called a “mammoth logistical operation”.


The opinion poll, by public opinion research firm Kantar, showed 22 per cent of respondents saying they would definitely or probably not get a coronavirus vaccine, rising to 38 per cent of 18-24 year-olds.

Only 5 per cent of those aged 65 and over and 16 per cent of those aged 55-64 said they would probably or definitely not get vaccinated.

Kantar said the poll found that 75 per cent of people with a degree-level of education planned to get the vaccine compared with 57 per cent of people without one.

Hancock said on Tuesday that vaccinations for Covid-19 will be optional.

'Vaccine mistrust will undermine efforts to tackle pandemic'

Meanwhile, an 80 per cent uptake of a Covid-19 vaccine may be needed to protect communities from the novel coronavirus, but volatile levels of misinformation and vaccine mistrust could undermine efforts to tackle the pandemic, British scientists said on Tuesday.

A report by scientific institutions - the British Academy and the Royal Society - found that, in part due to circulating misinformation and behavioural factors, around 36 per cent of people in Britain say they are either uncertain or very unlikely to agree to be vaccinated against Covid-19.

It said an “open dialogue” is critical to building public support for Covid-19 vaccination, and called for a “frank conversation” to manage public expectations that life will not immediately get back to normal when vaccines arrive.

“Vaccines and vaccination are two very different things. To achieve the estimated 80% of uptake of a vaccine required for community protection, we need a serious, well-funded and community-based public engagement strategy,” said Melinda Mills, an Oxford University professor and expert in demographic science who led the report.

Opinion polls carried out before and during the Covid-19 pandemic across many countries show that confidence in vaccines is volatile, and that political polarization and online misinformation are likely to affect rates of uptake.

“We must learn from lessons of history and move away from the one-way provision of information and instead generate an open dialogue that addresses misinformation and does not dismiss people’s real vaccine concerns and hesitancy,” Mills said.

The report also said governments should plan now for a “phased and ethical” vaccine deployment based on transparent principles that are “sufficiently debated with the public to build understanding”.

It recommended priority groups should include health and care workers and other high-risk occupations such as teachers, bus drivers and retail workers, as well as vulnerable groups in crowded situations such as the homeless and people in prisons.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less